Occurrcnce of extended-spectrum beta-lactamases in isolates of klebsiella pneumoniae and escherichia coli

International Journal of Integrative Biology

Volumn 2, Issue 2, 2008, Pages 122-128

  El Astal, Zakaria Y ^a   Ramadan, Hanan ^a  

^a Nasser Hospital Laboratory   (Palestine)

Author keywords

Antimicrobial Susceptibility; E. coli; ESBL; K. Pneumoniae

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; COTRIMOXAZOLE; DOXYCYCLINE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; MEROPENEM; NALIDIXIC ACID; OFLOXACIN; PHOSPHATIDYLETHANOLAMINE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISK DIFFUSION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; FEMALE; HUMAN; MALE; NONHUMAN; PALESTINE;

EID: 77649128344     PISSN: 09738363     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Al-Zarouni M, Senok A et al. (2008) Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Med. Princ. Pract. 17(1): 32-36.
2. Astal Z (2004) Susceptibility patterns in Pseudomonas aeruginosa causing nosocomial infections. J. Chemother. 16(3): 264-268.
3. Babini GS, Livermore DM (2000) Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998. J. Antimicrob. Chemother. 45: 183-189.
4. Babypadmini S, Appalaraju B (2004) Extended spectrum-lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae-Prevalence and susceptibility pattern in a tertiary care hospital. Indian J. Med. Microbiol. 22(3): 172-174.
5. Bishara J, Livne G et al. (2005) Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Isr. Med. Assoc. J. 7(5): 298-301.
6. Cantón R, Novais A et al. (2008) Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. CMI. 14(1): 144-153.
7. De Champs C, Sirot, D et al. (2000) A 1998 survey of extended-spectrum beta-lactamases in Enterobacteriaceae in France. Antimicrob Agents Chemother. 44: 3177-3179.
8. Del Carmen Rodriguez M et al. (2004) Phenotypic confirmation of extended-spectrum B-lactamascs (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center. P R Health Sci J. 23(3): 207-215.
9. Diaz P.Q., Bello H.T. et al. (2004) Resistance to gentamicin, amikacin and ciprofloxacin among nosocomial isolates of Klebsiella pneumoniae subspecie pneumoniae producing extended spectrum beta-lactamases. Rev. Med. Chil. 132(10): 1173-1178.
10. Drieux L, Brossier F et al. (2008) Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide. CMI. 14(1): 90-103.
11. Hawkey PM (2008) Prevalence and clonality of extended-spectrum β-lactamases in Asia. CMI. 14(1): 159-165.
12. Hirakata Y, Matsuda J et al. (2005) Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn. Microbiol Infect. Dis. 52(4): 323-329.
13. Hope R, Warner M et al. (2006) Activity of tigecycline against ESBL-producing and AmpC-hyperproducing Enterobacteriaceae from South-East England. J. Antimicrob Chemother. 58(6): 1312-1314.
14. Hosoglu S, Gundes S et al. (2007) Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals. Indian J. Med. Microbiol. 25(4): 346-350.
15. Kader AA, Kumar A (2005) Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital. Ann. Saudi Med. 25(3): 239-242.
16. Kjcrulf A, Hansen DS et al. (2008) The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark. APMIS. 116(2): 118-124.
17. Lin MF, Huang ML et al. (2003) Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan. J. Hosp. Infect. 53: 39-45.
18. rd edition Philadelphia, Lippincott Williams and Wilkinson.
19. Mendonca N, Leitão J et al. (2007) Spread of extended-spectrum β-lactamase ctx-m-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob Agents Chemother. 51(6): 1946-1955.
20. thinformational supplement. CLST document M l 00-S I 5. Wayne, PA: CLSI.
21. Ndugulile F, Jureen R et al. (2005) Extended spectrum β-lactamases among Gram-negative bacteria of nosocomial origin from an Intensive Care Unit of a tertiary health facility in Tanzania. BMC Infect. Dis. 5: 86.
22. Nijssen S, Florijn A et al. (2004) Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents. 24(6): 585-591.
23. Ozgunes I, Erben N et al. (2006) The prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors. Saudi Med J. 27(5): 608-612.
24. Paterson DL, Ko WC et al. (2004) Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum b-lactamases. Antibiotics for ESBL Producers CID: 39(1): 31-37.
25. Perez F, Endimiani A et al. (2007) The continuing challenge of ESBLs. Curr. Opin. Pharmacol. 7(5): 459-469.
26. Romero EDV, Padilla TP et al. (2007) Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum β-lactamases. Diagn Microbiol Infect Dis. 59(4): 433-437.
27. Shah A A, Hasan F et al. (2003) Prevalence of extended spectrum β-lactamases in nosocomial and outpatients (ambulatory). Pak. J. Med. Sci. 19(3): 187-191.
28. Spanu T, Sanguinetti M et al. (2006) Evaluation of the new VITEK 2 extended-spcctrum beta-lactamasc (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates. J. Clin. Microbiol. 44(9): 3257-3262.
29. Tumbarello M, Sanguinetti M et al. (2007) Predictors of mortality in patients with bloodstream infections caused by cxtcndcd-spcctrum-β-lactamasc-producing Enterobacteriaceae. Importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother. 51(6): 1987-1994.
30. Tzelepi E., Magana Ch. et al. (2003) Extended-spectrum β-lactamasc types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals. Int. J. Antimicrob. Agents 21(3): 285-288.
31. Villanueva FD, Tupasi TE et al. (2003) Extended-spectrum b-lactamase Production among Escherichia coli and Klebsiella spp. at the Makati Medical Center: Tentative Solutions. Phil J Microbiol Infect Dis. 32(3): 103-108.
32. Xiong Z, Zhu D et al. (2002) Extended-spcctrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates. Zhonghua Yi Xue Za Zhi. 21: 1476-1479.